Abstract: The invention relates to a method of treating inflammatory conditions in a subject comprising administering to a subject a composition comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4 polypeptide variant. The invention also provides a method of promoting wound healing in a subject comprising administering to the subject a composition comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4 polypeptide variant. The invention also relates to methods of treating the above mentioned conditions in a subject comprising administering to the subject a nucleic acid encoding a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4 polypeptide variant. The invention also relates to pharmaceutical compositions comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4 polypeptide variant, or salt thereof, and a pharmaceutically acceptable carrier.

Abstract: The invention relates to a method of treating inflammatory conditions in a subject comprising administering to a subject a composition comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4polypeptide variant. The invention also provides a method of promoting wound healing in a subject comprising administering to the subject a composition comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4polypeptide variant. The invention also relates to methods of treating the above mentioned conditions in a subject comprising administering to the subject a nucleic acid encoding a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4 polypeptide variant. The invention also relates to pharmaceutical compositions comprising a lymphoid thymosin-?4 polypeptide or a functional lymphoid thymosin-?4polypeptide variant, or salt thereof, and a pharmaceutically acceptable carrier.

Abstract: Readily soluble dry diet beverage crystals capable of providing a low calorie beverage upon dissolution in water and comprising a matrix of an essential oil flavorant, a dipeptide sweetener, a water-soluble edible gum and crystalline sugar are disclosed. A process whereby a homogeneous slurry of the same ingredients is prepared and dried is also disclosed.

Abstract: A heat sensitive liquid is vaporized with minimum degradation by introducing it via an atomizer into an enclosed space together with a heated gas under pressure, and so that the gas circulates past heaters which are screened from the atomizer. Useful for vaporizing adipic acid into ammonia gas.